Ownership history in RENAISSANCE TECHNOLOGIES LLC Β· 24 quarters on record
This page tracks every 13F SEC filing in which RENAISSANCE TECHNOLOGIES LLC reported a position in ENTERA BIO LTD (ENTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π RENAISSANCE TECHNOLOGIES LLC outperformed the S&P 500 by +63.9% annually on this ENTX position. Timing score: 62% (10/16 decisions correct). Average cost basis: $1.52. Maximum drawdown during holding period: β84.3%.
π₯ Exceptional β beat the S&P 500 by 63.9% per year on this position.
16 quarters analyzed
β
Decent timing β more right than wrong on entries and exits.
10 of 16 add/trim decisions correct
Best entry: $0.60 (2023 Q4) Β· Worst: $3.81 (2021 Q1)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
13 adds Β· 5 trims. Bought during 5 of 7 down-price quarters. π Consistently bullish β fund kept accumulating this position.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.0% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size